Perceptive Advisors LLC Vaxcyte, Inc. Transaction History
Perceptive Advisors LLC
- $2.39 Billion
- Q1 2025
A detailed history of Perceptive Advisors LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 706,567 shares of PCVX stock, worth $26.3 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
706,567
Previous 1,718,417
58.88%
Holding current value
$26.3 Million
Previous $141 Million
81.03%
% of portfolio
1.12%
Previous 4.69%
Shares
11 transactions
Others Institutions Holding PCVX
# of Institutions
345Shares Held
136MCall Options Held
348KPut Options Held
250K-
Ra Capital Management, L.P. Boston, MA12.2MShares$453 Million9.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$448 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.8MShares$438 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$370 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA6.42MShares$239 Million0.05% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.21B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...